New award for DPP-4 sitagliptin with zydus pharmaceuticals (USA)INC. Period of performance is 5/18/2024 - 5/17/2025 with four one-year option periods.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79724D0021
- Awardee
-
Zydus Pharmaceuticals (USA) Inc. UEI QMFQCPLJ9F36
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Dipeptidyl-Peptidase 4 (DPP-4) Inhibitors Pre-Solicitation · 36E79723R0037 · Posted Oct 5, 2023
- Last date to order 82% complete
- IDV ceiling
- $113,797,620.00
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Acquisition Center awarded an indefinite-delivery contract to Zydus Pharmaceuticals (USA) Inc. for DPP-4 Sitagliptin supply on May 18, 2024, with a ceiling of $113,797,620. This is a single-award contract with no set-aside.
Place of performance is the VA facility in Hines, Illinois, with distribution through the VA's Pharmaceutical Prime Vendor Programs serving the Department of Veterans Affairs, Bureau of Prisons, and Indian Health Service.
The originating solicitation (RFP 36E79723R0037, posted October 5, 2023, due October 31, 2023) requested supply of an estimated annual 45,519,048 tablets of Dipeptidyl-Peptidase 4 inhibitors. The contractor must provide uninterrupted supply in all commercial package sizes except unit dose at a single price per tablet regardless of strength or package configuration.
The contract runs from May 18, 2024 through May 17, 2025, with four one-year option periods. NAICS code 325412 and PSC code 6515 (pharmaceutical preparations) apply. A modification effective April 2026 incorporated Section 5 of Executive Order 14398, Clause 52.222-90, addressing discrimination-related compliance for federal contractors.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 12
Quick answers
Who was awarded contract 36E79724D0021?
36E79724D0021 was awarded to Zydus Pharmaceuticals (USA) Inc. by National Acquisition Center (Headquarters) on May 18, 2024.
How much is contract 36E79724D0021 worth?
36E79724D0021's own ceiling is $113,797,620.
Who can order from contract 36E79724D0021?
36E79724D0021 is a single award indefinite delivery contract.
Was contract 36E79724D0021 competed?
The extent of competition for 36E79724D0021 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV